Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8969887 | Vaccine | 2005 | 7 Pages |
Abstract
The current findings suggested that P4 would be a useful antigen as the component of the vaccine to induce protective immune responses against NTHi. The use of an intranasal vaccine composed of the different surface protein antigens is an attractive strategy for the development of a vaccine against NTHi.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Muneki Hotomi, Yorihiko Ikeda, Masaki Suzumoto, Kazuma Yamauchi, Bruce A. Green, Gary Zlotnick, Dewan S. Billal, Jun Shimada, Keiji Fujihara, Noboru Yamanaka,